Title
Category
Credits
Event date
Cost
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
The presentation "Too Old to Treat?" by Cathleen Colón Emeric, MD, MHS, addresses the complexities of osteoporosis management in older adults, especially those with high comorbidity burdens, frailty, and limited life expectancy. It explores the concept of osteoporosis as a geriatric syndrome, discusses methods to estimate fracture risk and life expectancy without relying solely on DXA, and emphasizes shared decision-making using the "Geriatric 4 M's" framework.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
The presentation "Osteoporosis: A Surgical Perspective" by Eeric Truumees, MD, explores the impact of osteoporosis on spinal health and surgical outcomes. It provides an orthopedic spine surgeon’s perspective on the challenges associated with bone loss, fixation strength, and complications from surgical interventions like vertebroplasty and kyphoplasty.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
The presentation "Artificial Intelligence for Osteoporosis: Fact or Fiction" by Dr. Nicholas Fuggle explores the rapidly evolving role of artificial intelligence (AI) in the field of osteoporosis. It provides an overview of AI concepts, historical milestones, and the latest advancements in machine learning and computer vision applied to bone health.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
The presentation "Year in Review" by E. Michael Lewiecki, MD, FACP, FACE, CCD, covers the latest research and clinical updates in the field of osteoporosis and vertebral compression fracture management. It provides a comprehensive overview of comparative effectiveness studies, updates on antiresorptive and anabolic therapies, and key findings from recent trials.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
The presentation "Bone Health in the Cancer Setting" by Matthew T. Drake, MD, Ph.D., from the Mayo Clinic College of Medicine, explores the relationship between cancer, cancer therapies, and bone health. It discusses the mechanisms by which cancer and its treatments contribute to bone loss and increased fracture risk.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
The presentation "DXA Screening for Technologists and Clinicians" by Diane Krueger, BS, CBDT, from the University of Wisconsin Madison, covers best practices in bone density screening using Dual Energy Xray Absorptiometry (DXA). It provides insights into recommended screening protocols, the use of DXA to enhance fracture risk assessment, and common pitfalls that can affect the accuracy of DXA exams.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
The presentation "Health Equity in the Management of Osteoporosis in Multiethnic Societies" by Nicole C. Wright, PhD, MPH, highlights the disparities in osteoporosis screening, treatment, and outcomes across different racial and ethnic groups. It reviews the latest data on racial disparities in bone density testing, fracture risk, and healthcare access.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
The presentation "TOPAZ: A Trial Preventing Fractures in Parkinson’s Disease Patients" by Kenneth W. Lyles, MD, from Duke University and VA Medical Centers, addresses the heightened risk of fractures in patients with Parkinson’s Disease (PD) and discusses the rationale and methodology of the TOPAZ trial.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
The presentation "Current Approaches to Long-term Osteoporosis Management" by Benjamin Leder, MD, explores various osteoporosis treatments, focusing on both antiresorptive and anabolic therapies. It discusses the benefits, limitations, and potential long-term strategies for managing osteoporosis, emphasizing the importance of individualized treatment plans.
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ANCC
  • 0.75 Participation
  • 0.75 Participation/Attendance
$45.00
The presentation, "Day-to-day Operations of the FLS Program Coordinator Role," provides an in depth look at the responsibilities, challenges, and strategies involved in running a successful Fracture Liaison Service (FLS) program. It emphasizes the essential role of the FLS Coordinator in closing the osteoporosis care gap, managing patients post-fracture, and promoting interdisciplinary collaboration for optimal outcomes.

Pages